Symbols

TEM

Tempus AI·NASDAQ

--(--)

TEM fundamentals

TEM Q4 2025 Earnings

Tempus AI (TEM) released its earnings on Feb 24, 2026: revenue was 367.21M (YoY +82.98%), beat estimates; EPS was -0.04 (YoY +77.78%), beat estimates.

Revenue / YoY

367.21M

+82.98%

EPS / YoY

-0.04

+77.78%

Report date

Feb 24, 2026

TEM Earnings Call Summary for Q4,2025

Revenue Surge: 33% YoY total revenue growth, 29% Diagnostics unit growth, 69% Data Licensing expansion.
MRD Breakthrough: 56% QoQ MRD growth, 20x scaling potential with full sales force deployment.
ASP Target: $2,200+ by 2026 via FDA approvals and payer rate hikes.
Data Dominance: $1.1B TCV, 126% net retention, 40% Licensing growth driven by unique multimodal data advantage.
Foundation Model: Internal tests show 10+ biomarker improvements, targeting AZ validation.

Earnings

EPS

Revenue

Revenue & Expenses

TEM has released its 2025 Q4 earnings report, with revenue of 367.21M, reflecting a YoY change of 82.98%, and net profit of -54.17M, showing a YoY change of -316.21%. The Sankey diagram below clearly presents TEM's revenue sources and cost distribution.

Key Indicators

Tempus AI (TEM) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Tempus AI (TEM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Tempus AI (TEM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Tempus AI (TEM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown